Delivery Order SPE2DB22D2007-SPE2DB25FJ1BB

Award Date 4/29/25
Potential Completion Date 5/20/25
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Tasigna 150 mg capsules in 28-count packages, with a ceiling value of $11,638.02 and a period of performance through March 26, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the prescription medication Tasigna (nilotinib) 150 mg capsules, with a ceiling value of $12,015.80. The contract is a firm fixed-price delivery order, with a period of performance through May 6, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tasigna 200 mg capsules, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $5,819.01 and runs through March 4, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TASIGNA 150 MG CAPSULE 28S. The contract has a ceiling value of $16,873.86 and an ultimate completion date of October 2, 2024. It is a firm fixed-price contract for the delivery of these prescription drug products. The contract is not set aside for any specific business category. AmerisourceBergen, through its extensive supply chain network,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tasigna (nilotinib) 150 mg capsules. The $5,624.62 firm fixed price contract has an ultimate completion date of August 6, 2024. This order is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,436 units of Tasigna 150 mg capsules in 28-count packages, with a ceiling value of $5,624.62. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This...
This is a $6,007.90 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a medication, with a period of performance through April 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tasigna (Nilotinib) 200 mg capsules. The contract has a ceiling value of $5,624.62 and an ultimate completion date of January 12, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of TASIGNA 150 MG CAPSULE 28S, a pharmaceutical product, with a firm fixed price of $11,249.24 and a completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order with a firm fixed price of $11,638.02 and a completion date of March 25, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply TASIGNA 150 MG CAPSULE 28S. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1BB
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tasigna 150 mg capsules, a medication used to treat certain types of cancer. The contract has a total ceiling value of $6,007.90 and is a firm fixed-price delivery order, with a period of performance through May 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract supports the DLA's medical supply procurement needs, particularly for military and veteran healthcare systems.

Generated 7/29/25, 9:59 AM